These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22626939)

  • 1. Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses.
    Bradshaw AC; Coughlan L; Miller AM; Alba R; van Rooijen N; Nicklin SA; Baker AH
    J Control Release; 2012 Dec; 164(3):394-402. PubMed ID: 22626939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.
    Alba R; Bradshaw AC; Coughlan L; Denby L; McDonald RA; Waddington SN; Buckley SM; Greig JA; Parker AL; Miller AM; Wang H; Lieber A; van Rooijen N; McVey JH; Nicklin SA; Baker AH
    Blood; 2010 Oct; 116(15):2656-64. PubMed ID: 20610817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
    Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT
    Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.
    Alba R; Bradshaw AC; Parker AL; Bhella D; Waddington SN; Nicklin SA; van Rooijen N; Custers J; Goudsmit J; Barouch DH; McVey JH; Baker AH
    Blood; 2009 Jul; 114(5):965-71. PubMed ID: 19429866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction.
    Corjon S; Gonzalez G; Henning P; Grichine A; Lindholm L; Boulanger P; Fender P; Hong SS
    PLoS One; 2011; 6(5):e18205. PubMed ID: 21637339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X.
    Bradshaw AC; Parker AL; Duffy MR; Coughlan L; van Rooijen N; Kähäri VM; Nicklin SA; Baker AH
    PLoS Pathog; 2010 Oct; 6(10):e1001142. PubMed ID: 20949078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.
    Koizumi N; Mizuguchi H; Sakurai F; Yamaguchi T; Watanabe Y; Hayakawa T
    J Virol; 2003 Dec; 77(24):13062-72. PubMed ID: 14645563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
    Ma J; Duffy MR; Deng L; Dakin RS; Uil T; Custers J; Kelly SM; McVey JH; Nicklin SA; Baker AH
    PLoS Pathog; 2015 Feb; 11(2):e1004673. PubMed ID: 25658827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity.
    Krutzke L; Prill JM; Engler T; Schmidt CQ; Xu Z; Byrnes AP; Simmet T; Kreppel F
    J Control Release; 2016 Aug; 235():379-392. PubMed ID: 27302248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human full-length coagulation factor X and a GLA domain-derived 40-mer polypeptide bind to different regions of the adenovirus serotype 5 hexon capsomer.
    Sumarheni S; Hong SS; Josserand V; Coll JL; Boulanger P; Schoehn G; Fender P
    Hum Gene Ther; 2014 Apr; 25(4):339-49. PubMed ID: 24512117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus serotype 5 hexon mediates liver gene transfer.
    Waddington SN; McVey JH; Bhella D; Parker AL; Barker K; Atoda H; Pink R; Buckley SM; Greig JA; Denby L; Custers J; Morita T; Francischetti IM; Monteiro RQ; Barouch DH; van Rooijen N; Napoli C; Havenga MJ; Nicklin SA; Baker AH
    Cell; 2008 Feb; 132(3):397-409. PubMed ID: 18267072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.
    Stepanenko AA; Chekhonin VP
    Virus Res; 2018 Sep; 257():40-51. PubMed ID: 30125593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo.
    Kalyuzhniy O; Di Paolo NC; Silvestry M; Hofherr SE; Barry MA; Stewart PL; Shayakhmetov DM
    Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5483-8. PubMed ID: 18391209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats.
    Nicol CG; Graham D; Miller WH; White SJ; Smith TA; Nicklin SA; Stevenson SC; Baker AH
    Mol Ther; 2004 Aug; 10(2):344-54. PubMed ID: 15294181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
    Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
    J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction
    Lopez-Gordo E; Doszpoly A; Duffy MR; Coughlan L; Bradshaw AC; White KM; Denby L; Nicklin SA; Baker AH
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retargeting of gene expression using endothelium specific hexon modified adenoviral vector.
    Kaliberov SA; Kaliberova LN; Hong Lu Z; Preuss MA; Barnes JA; Stockard CR; Grizzle WE; Arbeit JM; Curiel DT
    Virology; 2013 Dec; 447(1-2):312-25. PubMed ID: 24210128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors.
    Greig JA; Buckley SM; Waddington SN; Parker AL; Bhella D; Pink R; Rahim AA; Morita T; Nicklin SA; McVey JH; Baker AH
    Mol Ther; 2009 Oct; 17(10):1683-91. PubMed ID: 19603000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic strategy to decrease complement activation with adenoviral therapies.
    Gentile CM; Borovjagin AV; Richter JR; Jani AH; Wu H; Zinn KR; Warram JM
    PLoS One; 2019; 14(4):e0215226. PubMed ID: 31026285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.
    Schoggins JW; Falck-Pedersen E
    J Virol; 2006 Nov; 80(21):10634-44. PubMed ID: 16943295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.